Literature DB >> 34802880

Acquired MET-DSTN Fusion Mediated Resistance to EGFR-TKIs in Lung Adenocarcinoma and Responded to Crizotinib Plus Gefitinib: A Case Report.

Yalun Li1, Ke Wang2, Panwen Tian3, Weimin Li4.   

Abstract

Entities:  

Keywords:  Acquired resistance; Combined treatment; Crizotinib; MET fusions; NSCLC

Mesh：

Substances：

Year:  2021        PMID： 34802880     DOI： 10.1016/j.cllc.2021.10.006

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN： 1525-7304            Impact factor:   4.785


× No keyword cloud information.
  1 in total

1.  Case report: Salvage capmatinib therapy in KIF5B-MET fusion-positive lung adenocarcinoma with resistance to telisotuzumab vedotin.

Authors:  Chien-Yu Lin; Sheng-Huan Wei; Yi-Lin Chen; Chung-Ta Lee; Shang-Yin Wu; Chung-Liang Ho; Dean C Pavlick; Po-Lan Su; Chien-Chung Lin
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.